Compliance

  • April 29, 2026

    FCC Looks To Update How It Collects Broadband Map Data

    The Federal Communications Commission has its eye on the National Broadband Map, with plans to vote next month on launching a proceeding to explore how to cut red tape from the data collection process while also increasing the accuracy of the data being collected.

  • April 29, 2026

    J&J, Neutrogena Say FDA Signed Off On Benzene Products

    Johnson & Johnson Consumer Inc. and Kenvue Inc. are calling for a permanent end to a multistate consumer lawsuit claiming their Clean & Clear and Neutrogena acne treatments degrade into the cancer-causing chemical benzene, arguing in New Jersey federal court that federal regulators have already determined that the key ingredient is safe.

  • April 29, 2026

    Uber's Latest Bellwether Loss Could Portend Trouble For Co.

    Uber was recently hit with another unfavorable verdict in the second bellwether trial in multidistrict litigation over driver sex assaults, and another determination that the ride-hailing company can be liable for its drivers' negligence does not bode well for the company, experts said.

  • April 29, 2026

    Deloitte Can't Duck Bulk Of Vax Software Theft Suit

    Deloitte must face an inventor's trade secrets misappropriation claims accusing the consulting giant of ripping off her firm's proprietary vaccination management system and securing a multimillion-dollar government contract to track the rollout of COVID-19 vaccines.

  • April 29, 2026

    CFTC Taps Agency Veteran To Run Its Whistleblower Office

    The Commodity Futures Trading Commission announced Wednesday that it has named as the director of its whistleblower office an agency litigation attorney who also has experience as a trial attorney in its enforcement division.

  • April 29, 2026

    Burgum, Senate Dems Spar Over Energy Permitting Moves

    U.S. Secretary of the Interior Doug Burgum on Wednesday blasted a federal court's recent pause of policies that imposed stricter reviews on wind and solar projects as Senate Democrats said such moves could kill the chances for significant permitting reform legislation.

  • April 29, 2026

    Powell Says He'll Stay On Fed Board After Time As Chair Ends

    Federal Reserve Chair Jerome Powell said Wednesday that he won't immediately leave the central bank once his term ends next month and plans instead to remain on its board temporarily, pointing to the Trump administration's recent "legal attacks" on the institution.

  • April 29, 2026

    Sunsetting FCC High-Cost Programs Could Undergo 'Refresh'

    Federal Communications Commission leaders during their meeting next month will weigh reforms to longstanding programs that help fund broadband deployment to rural and other "high cost" areas.

  • April 29, 2026

    CEO Stole From His Company To Buy Mansion, SEC Says

    The former CEO of a California-based pharmaceutical company agreed Wednesday to pay the U.S. Securities and Exchange Commission $30,000 to end a lawsuit accusing him of misappropriating $3.2 million in company funds partly to buy a Beverly Hills mansion.

  • April 29, 2026

    Ulta Loses Bid To Toss Wash. Consumers' Spam Email Claims

    A Spokane federal judge refused to toss a proposed class action alleging cosmetics giant Ulta sent Washington residents deceptive emails advertising "free gifts" and discounts without disclosing purchase qualifications, saying the complaint plausibly alleges the emails violate state consumer protection laws.

  • April 29, 2026

    FTC's BOTS Suit Survives Because Law Not Just About Bots

    A Maryland federal judge has refused to dismiss one of the Federal Trade Commission's first-ever online ticketing cases, rejecting ticket reseller arguments that their use of thousands of Ticketmaster accounts to buy concert tickets is immune because they don't use bots.

  • April 29, 2026

    NY Says Crypto Co. To Pay $5M Over Fraud Promotion Claims

    Cryptocurrency platform operator Uphold HQ Inc. will pay $5 million to settle claims from the New York attorney general's office that it promoted now-bankrupt Cred Inc.'s fraudulent, high-risk crypto scheme for which Cred's former executives were sentenced to prison last year.

  • April 29, 2026

    EPA Staff Challenge Suspensions Over Critical Open Letter

    Fifteen U.S. Environmental Protection Agency employees have filed complaints with the U.S. Office of Special Counsel, alleging the agency unlawfully suspended them after they signed a public "declaration of dissent" against the Trump administration's policies.

  • April 29, 2026

    Novo Nordisk Rejects Claim It Influences GLP-1 Market

    Pharmaceutical giant Novo Nordisk told a Texas federal judge that it does not control the GLP-1 market and has not attempted to crush its competition in a bid to dismiss an antitrust suit it is facing.

  • April 29, 2026

    PBMs Say Michigan AG Price-Fixing Suit Is Unsound

    Pharmacy benefit managers Express Scripts, Evernorth Health and Prime Therapeutics have bolstered their effort to escape a federal price-fixing suit brought against them by Michigan's attorney general by arguing the statutes cited in the complaint do not apply to them.

  • April 29, 2026

    Mass. AG, Insurer Settle Deceptive Marketing Claims For $5M

    A Texas-headquartered health insurance agency will pay $5 million to settle allegations that it engaged in deceptive and unfair marketing to sell plans and other types of health programs to thousands of Massachusetts consumers, the state's attorney general announced on Wednesday.

  • April 29, 2026

    NCAA Bans Former Fordham Players After Game-Fixing Probe

    Two former Fordham University basketball players will be permanently ineligible for NCAA competition following a sports-betting integrity investigation related to the federal charges prosecutors have lodged against more than two dozen people for allegedly conspiring to rig games, according to the NCAA.

  • April 29, 2026

    Coupang, Ex-In-House Lawyer To Drop Iran Whistleblower Suit

    South Korean e-commerce giant Coupang and a former in-house compliance attorney have agreed to dismiss the lawyer's suit claiming he was wrongly fired for bringing attention to the company's alleged illegal business dealings with Iran, according to a joint filing Wednesday in Seattle federal court.

  • April 29, 2026

    Robinhood Hires Morgan Lewis Atty For Senior Counsel Role

    A former Morgan Lewis & Bockius LLP attorney has moved to Robinhood to join the financial trading platform's litigation and regulatory enforcement team. 

  • April 29, 2026

    Rambus Being Probed By DOJ Antitrust Unit

    Rambus has received a grand jury subpoena in connection to an investigation by the U.S. Department of Justice's Antitrust Division, according to an investor filing from the chipmaker and technology company.

  • April 29, 2026

    GCs, Now That You're At The Table, How Fast Can You Lead?

    For general counsel, the pivotal question is no longer do they have a seat at the leadership table, but can they design a legal operation to run at the speed of modern decision-making.

  • April 29, 2026

    Florida Atty Settles SEC Claims Over Gem Investment Fraud

    The U.S. Securities and Exchange Commission announced a Florida attorney will pay more than $26,000 to settle claims in Georgia federal court that he aided a million-dollar gold and diamond investment fraud scheme by receiving and disbursing investor funds and ignoring red flags.

  • April 29, 2026

    Bausch Balks At Suspected Tweak In Price-Fixing Deals

    A stipulation between state attorneys general and private plaintiffs suing generic-drug makers for alleged price-fixing seems to reflect a change in the states' earlier deal to release claims against Bausch entities, the companies said in asking a Connecticut federal judge to maintain the status quo.

  • April 29, 2026

    AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit

    When the federal government included Botox in Medicare's drug price negotiation program, which allows Medicare officials to negotiate for lower drug prices, it overstepped its authority, drugmaker AbbVie Inc. told a D.C. federal court, arguing the cosmetic drug and migraine treatment is a "plasma-derived" product ineligible for price controls.

  • April 29, 2026

    Unions Ask Congress To Enact Worker-Friendly AI Legislation

    Labor protections must be at the forefront of any new federal laws that aim to rein in the explosion of artificial intelligence technology across the economy, according to a letter to Congress from the AFL-CIO and 39 other groups.

Expert Analysis

  • Mapping Philly US Atty's White Collar Enforcement Push

    Author Photo

    Attorneys at Blank Rome discuss the U.S. Attorney for the Eastern District of Pennsylvania David Metcalf’s commitments and priorities, survey early results from his first year, and suggest practical action items for companies operating under the office's jurisdiction.

  • Opinion

    Exxon's Retail Voting Program Is A Trap For Retail Investors

    Author Photo

    The U.S. Securities and Exchange Commission approved Exxon Mobil's first-of-its-kind proxy voting program last September, but ahead of the company's annual shareholder meeting next month, it's clear that retail shareholders have delegated their voice to the entity their vote exists to check, says Christina Sautter at Southern Methodist University.

  • Structuring Bank-Fintech Ties To Avert Risk

    Author Photo

    Bank-fintech relationships that can hold up to recent increased scrutiny must take into account a broad swath of structuring considerations including due diligence, compliance, documentation, and planning for a potential wind-down and termination, say attorneys at Nelson Mullins.

  • What DOL Proposal Signals For 401(k)s, Alternative Assets

    Author Photo

    The U.S. Department of Labor recently published a highly anticipated proposed rule that could establish more defined pathways for 401(k) plan fiduciaries to consider investment options with greater alternative asset exposure, and help fund sponsors and investment managers develop such options, say attorneys at Cleary.

  • DOJ's Superseding Policy Muddies Trade Crime Disclosures

    Author Photo

    The U.S. Department of Justice’s first agencywide voluntary self-disclosure policy is intended to standardize approaches across DOJ components, but the shift may prove difficult in trade controls cases under the National Security Division, which has long viewed sanctions and export control offenses as uniquely serious, say attorneys at Covington.

  • SEC's Enforcement Slowdown May Raise Oversight Questions

    Author Photo

    After six months of enforcement activity, it's clear that fiscal year 2026 will see an unprecedented decline in U.S. Securities and Exchange Commission enforcement activity relative to past years, but whether the SEC will be viewed as sufficiently policing the securities markets at the end of the fiscal year is more uncertain, say attorneys at Covington.

  • How Food, Beverage Claims May Preview Cosmetic Litigation

    Author Photo

    Class action litigation targeting cosmetics and personal care products is accelerating, with a playbook that comes from the food and beverage industry — and the defenses that succeeded, and failed, in past class actions offer a critical road map for beauty and personal care brands, say attorneys at Crowell.

  • Steps To Consider As DOJ Launches Fraud Division

    Author Photo

    The establishment this month of the National Fraud Enforcement Division within the U.S. Department of Justice is a significant reorganization that suggests an increase in enforcement activity involving federally funded programs but leaves a number of important questions unanswered, say attorneys at Crowell & Moring.

  • Court's HRSA Policy Reversal Leaves 340B Rules Murky

    Author Photo

    A D.C. federal court's recent decision in Premier v. U.S. Department of Health limits the Health Resources and Services Administration's ability to enforce long-standing Section 340B interpretations through subregulatory guidance, leaving open core statutory questions about purchasing models, inventory classification and program oversight, says Martha Cramer at Hooper Lundy.

  • What We Did And Didn't Learn From DOJ's 1st Illegal DEI Deal

    Author Photo

    IBM's recent $17 million deal with the U.S. Department of Justice marks the first resolved False Claims Act enforcement action under the Civil Rights Fraud Initiative, and while it validates the core of the government's FCA antidiscrimination enforcement road map, it leaves its most aggressive theories untested, say attorneys at Nutter.

  • What Cos. Must Know As Energy Star Shifts To DOE Oversight

    Author Photo

    Congress saved the Energy Star program last year despite the Trump administration's attempt to defund it — but as its management shifts from one federal agency to another, industry participants need to track what's changing to stay abreast of compliance obligations, say attorneys at HWG.

  • What To Expect From The SEC's New SOX Group

    Author Photo

    In a potential shift away from Public Company Accounting Oversight Board enforcement, the U.S. Securities and Exchange Commission's formation of a new group to investigate and litigate potential violations of the Sarbanes-Oxley Act brings both risks and benefits for auditors, say attorneys at King & Spalding.

  • Contract Language Reigned Supreme In Bancorp Dismissal

    Author Photo

    A Minnesota federal court's recent dismissal of claims over U.S. Bancorp's cash sweep program underscores that clear contractual disclosures hold weight in class actions, demonstrating the power of contract language that plainly indicates terms, fiduciary limits and institutional benefits to customers, says Quin Seiler at Winthrop & Weinstine.

  • Why Justices Seem Skeptical Of Curbing SEC Disgorgement

    Author Photo

    Sripetch v. U.S. Securities and Exchange Commission presents an opportunity for the U.S. Supreme Court to clarify the disgorgement limits it set six years ago in Liu v. SEC, with recent oral arguments suggesting the court sees disgorgement as an equitable remedy akin to unjust enrichment, say attorneys at Hueston Hennigan.

  • New DEI Clauses Will Reshape FCA Exposure For Contractors

    Author Photo

    As federal agencies mandate new procurement language aimed at curbing contractors' DEI practices and embedding False Claims Act materiality concepts into antidiscrimination obligations, contractors should account for both compliance and litigation risks before signing, and understand the legal constraints that govern FCA materiality, say attorneys at Seyfarth.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.